Establishment of government-initiated comprehensive stroke centers for acute ischemic stroke management in South Korea

Stroke

Volumn 45, Issue 8, 2014, Pages 2391-2396

  Kim, Jei ^a   Hwang, Yang Ha ^b   Kim, Joon Tae ^c   Choi, Nack Cheon ^d   Kang, Sa Yoon ^e   Cha, Jae Kwan ^f   Ha, Yeon Soo ^g   Shin, Dong Ick ^h   Kim, Seongheon ⁱ   Lim, Byeong Hoon ^d  

^a Chungnam National University College of Medicine   (South Korea)

^b Daegu Gyeongbuk Development Inst   (South Korea)

^c Gwangju Jeonnam Reg Small MBA   (South Korea)

^d Gyeongnam Regional Cardiocerebrovascular Disease Center   (South Korea)

^e Jeju Regional Cancer Center   (South Korea)

^f Busan Ulsan Regional Cardiocerebrovascular Center   (South Korea)

^g Jeonbuk Regional Cerebrovascular Center   (South Korea)

^h Chungbuk Regional Cerebrovascular Center   (South Korea)

ⁱ Gangwon Regional Cerebrovascular Center   (South Korea)

Author keywords

comprehensive stroke care; South Korea; thrombolytic therapy

Indexed keywords

AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL EVALUATION; DATA ANALYSIS; EMERGENCY WARD; FEMALE; FIBRINOLYTIC THERAPY; GOVERNMENT; HEALTH CENTER; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; MORTALITY; NEUROIMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOUTH KOREA;

COMPREHENSIVE STROKE CARE; SOUTH KOREA; THROMBOLYTIC THERAPY;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; DISEASE MANAGEMENT; FEMALE; FIBRINOLYTIC AGENTS; GOVERNMENT; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; MORTALITY; REPUBLIC OF KOREA; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84906101345     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.006134     Document Type: Article

References (23)

1. Causes of Death in South Korea, 2012. Korea National Statistics Office Web site. http://www.index.go.kr/potal/main/EachDtlPageDetail.do?idx- cd=1012. Accessed April 6, 2014 (Korean).
2. A study on measuring the economic burden of cardio-cerebrovascular disease in Korea. Korea Centers for Disease Control and Prevention Web site. http://www.cdc.go.kr/CDC/info/CdcKrInfo0201. jsp?menuIds=HOME001-MNU1155-MNU1083-MNU1375- MNU0025&fid=28&q-type=&q-value=&cid=1662&pageNum=1. Accessed April 6, 2014 (Korean).
3. Hong KS, Bang OY, Kang DW, Yu KH, Bae HJ, Lee JS, et al. Stroke statistics in Korea: Part I. epidemiology and risk factors: a report from the Korean Stroke Society and Clinical Research Center for Stroke. J Stroke. 2013;15:2-20.
4. A Project for Regional Cardiovascular and Cerebrovascular Center. Korea Centers for Disease Control and Prevention Web site. http://www.cdc.go.kr/ CDC/contents/CdcKrContentView.jsp?cid=22031&menuIds=HOME001- MNU1130-MNU1110-MNU1114. Accessed April 6, 2014 (Korean).
5. Meretoja A, Roine RO, Kaste M, Linna M, Roine S, Juntunen M, et al. Effectiveness of primary and comprehensive stroke centers: PERFECT stroke: a nationwide observational study from Finland. Stroke. 2010;41:1102-1107.
6. Gorelick PB. Primary and comprehensive stroke centers: history, value and certification criteria. J Stroke. 2013;15:78-89.
7. Ringelstein EB, Chamorro A, Kaste M, Langhorne P, Leys D, Lyrer P, et al; ESO Stroke Unit Certification Committee. European Stroke Organisation recommendations to establish a stroke unit and stroke center. Stroke. 2013;44:828-840.
8. Choi HY, Cha MJ, Nam HS, Kim YD, Hong KS, Heo JH; Korean Stroke Unit Study Collaborators. Stroke units and stroke care services in Korea. Int J Stroke. 2012;7:336-340.
9. Alberts MJ, Latchaw RE, Selman WR, Shephard T, Hadley MN, Brass LM, et al; Brain Attack Coalition. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke. 2005;36:1597-1616.
10. Tveiten A, Mygland A, Ljøstad U, Thomassen L. Intravenous thrombolysis for ischaemic stroke: short delays and high community-based treatment rates after organisational changes in a previously inexperienced centre. Emerg Med J. 2009;26:324-326.
11. Meretoja A, Strbian D, Mustanoja S, Tatlisumak T, Lindsberg PJ, Kaste M. Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology. 2012;79:306-313.
12. Fonarow GC, Smith EE, Saver JL, Reeves MJ, Hernandez AF, Peterson ED, et al. Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative. Stroke. 2011;42:2983-2989.
13. Fonarow GC, Zhao X, Smith EE, Saver JL, Reeves MJ, Bhatt DL, et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA. 2014;311:1632-1640.
14. Felberg RA, Okon NJ, El-Mitwalli A, Burgin WS, Grotta JC, Alexandrov AV. Early dramatic recovery during intravenous tissue plasminogen activator infusion: clinical pattern and outcome in acute middle cerebral artery stroke. Stroke. 2002;33:1301-1307.
15. Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke. 2010;41:2254-2258.
16. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, et al; SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012;340:1241-1249.
17. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al; Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368:893-903.
18. Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R, et al; SYNTHESIS Expansion Investigators. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013;368:904-913.
19. Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, et al; MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368:914-923.
20. Jeong HS, Kwon HJ, Kang CW, Song HJ, Koh HS, Park SM, et al. Predictive factors for early clinical improvement after intra-arterial thrombolytic therapy in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23:e283-e289.
21. The top 10 causes of death. World Health Organization Web site. http:// www.who.int/mediacentre/factsheets/fs310/en/. Accessed April 6, 2014.
22. Global and Health and Aging. World Health Organization Web site. http:// www.who.int/ageing/publications/global-health/en/. Accessed April 27, 2011.
23. The 2012 Ageing Report: Economic and budgetary projections for the EU-27 Member States (2010-2060). Directorate-General for Economic and Financial affairs of the European Commission. 2012.